|
|
Other links at Articles > Pathology and Lab Medicine |
| 2. |
Cells Engineered to Reduce Arterial Plaque
|
|
|
Descendants of hematopoietic progenitor cells that were genetically engineered to express apolipoprotein AI (apoAI) counter the accumulation of cholesterol on artery walls, according to a study in mice by researchers from Vanderbilt University reported in the August issue of Arteriosclerosis, Thrombosis, and Vascular Biology. ApoAI is the major protein component of high-density lipoprotein. Reuters Health Information
|
|
|